Abstrak
Early diagnosis of central nervous system (CNS) lymphoma is important for proper treatment in both immune competent and immune compromised patients.
1,2 However, according to some studies 3, 4 and the fact that at our department, the CNS lymphoma incidence has increased in these last couple of years. So that lymphoma should be considered in the differential diagnosis for mass lesions found in the CNS, especially who previously healthy and presented with short clinical course.
Prognosis of CNS lymphoma is determined by response to the treatment and the advance of disease. In other words, early diagnosis followed with appropriate treatment would define the overall prognosis. Despite many challenges for early diagnosis, any clinical or radiological characteristics that can lead to early diagnosis or suspicion toward CNS lymphoma are very important.
The aim of the study was to describe the radiological findings and clinical characteristics of patients with CNS lymphoma. We hope this study would be able to help clinician when they gather the facts either to support or to rule out the CNS lymphoma.
METHODS

Medical records were analyzed retrospectively.
A complete list of patients histopathologically confirmed to have CNS lymphoma in our institution from November 2008 to December 2013 was made. This study has been approved by the Siloam Hospital Lippo Village Ethics and Research Committee. Medical records were then retrieved according to the list to get the patients' clinical data. The clinical data of the patients including the age, gender, HIV status, immune status based on the laboratory result, pathological and radiological findings, site and number of tumors, initial diagnosis, initial presenting symptoms, and duration between initial symptoms and confirmed diagnosis were obtained from the medical records. Magnetic resonance imaging (MRI) images were retrieved from the radiology department's digital database to determine the location and number of the tumors, and the radiological characteristics of the tumors. All of the patients' MRI results which were able to be retrieved were then reviewed again by a radiologist. For patients whose MRI results could not be retrieved, the data of the location and number of the tumors were obtained from the radiological expertise, which are available and contained in the medical records.
The retrieved data were of patients' initial condition and findings before the patients underwent biopsy. Statistical analysis was done by using SPSS for Windows version 16.0.
RESULTS
From November 2008 to December 2013, 32 patients were diagnosed histopathologically to have CNS lymphoma. The mean of age was 54 ± 15.01 years. Of those, 19 (59%) were males and 13 (41%) were female (M/F ratio is 1.5:1). The initial symptoms presented in the patients are described in table 1. The median interval between the onset of the initial symptoms and diagnosis is 7 weeks (range = 2-55 weeks, mean = 8.37 weeks). Thirty one of the patients were HIV negative, serology testing (Combo/ELISA or rapid test) for HIV was carried out for all cases except one case, with no other acquired immune compromised status such as history of transplantation, radiotherapy, or chemotherapy recorded in the medical records. All the patients showed normal leucocyte count (5,000 -11,000 cells/ µL) and all case showed normal CD4 level (CD4 > 500 cells/µL), except one case.
Of the 32 patients, only nine patients were suspected to have CNS lymphoma prior to biopsy in our hospital based on radiological and clinical findings alone. Others initial clinical diagnosis made prior to biopsy is unspecified tumor (7 patients) and glioma (12 patients). Two patients were suspected to have metastatic tumors, one as ependymoma, even multiple meningiomas (1 patient). Fourteen patients had solitary mass while the other had multiple patchy lesions without clear edges. The contrast enhance ment features are somehow looked like paint strokes. The patients' initial clinical presentation can be seen in table 1. The description of the tumor locations is displayed in table 2.
Twenty five of the patients' brain MR images were able to be retrieved and then reviewed by the inhouse radiologist, seven others could not be retrieved because the images were done at others hospital. Of these 25, seven patients were presented with intratumoral bleeding. Patients' brain MR images showed that all lesions were markedly enhanced with contrast, 21 out of 25 were in-homogeneous, some of them also showed features of central necrosis. In T1 weighted imaging (T1WI), 18 lesions were iso-hypointense, 5 were iso-hyperintense, and only 2 were hyperintense. In T2 weighted imaging (T2WI), the lesions were iso-to hypointense with area of hyperintense surrounding the enhanced area. In diffusion weighted imaging (DWI), only one lesion were not hyperintense (Figure 1 ), the one which was not had no restricted area. Seven patients (28%) showed hemorrhagic lesions (intratumoral bleeding). Three showed meningeal involvement. Of these twenty five, six patients showed more than one lesion (24%).
DISCUSSION
CNS lymphoma incidence in immune competent individuals can happen at all ages but a peak incidence is usually in the sixth decade of life with male predominance. 5 Since none of our subject was immunocompromised, this corresponds well with our findings. Immunocompromised state is a well-established risk factor for CNS lymphoma development. 1, 6 However, in our Figure 1 . A 62 year-old female, which underwent biopsy and confirmed to have a CNS lymphoma, presented with headache, cognitive impairment, and right hemiparesis. The MR images enhanced with contrast (A) showed that the lesion, was located at the left trunk of corpus callosum. T1W images showed an isointense lesion (B), while T2W images showed also an isointense lesion surrounded by significant edema (C), and high signal intensity on DW images (D) study, we are surprised that most of our cases are immunocompetent, based on the laboratory results. Moradi, et al 7 also noted that in their study, of 110 subjects, none were HIV positive. This fact suggests that while immuno compromised state is a wellestablished risk factor for CNS lymphoma, it is not a prominent factor. It's probably unnecessary to do routine check of CD4 count as part of our effort to determine the patient's immune status.
In our study, the median interval time between first symptom and diagnosis is 7 weeks. It is shorter compare to the previous report of 22 weeks. 7 This short clinical course should drive our attention to the CNS lymphoma.
Since lymphoma has no distinct or characteristic clinical and radiological features, it is difficult to differentiate it with other intracranial mass lesions by those features alone. 8, 9 The reason might be because most intracranial pathology presents with nonspecific symptoms (increased intracranial pressure, seizure, weakness, etc.) and differ in clinical A D C B presentations because of the difference in location, not the type of pathology. 6 Our findings suggest that CNS lymphomas are quite frequently mistaken for gliomas. The cause of this might be the clinical and radiological similarity between those two. Glioma frequently presents with headache, weakness, mental changes, and also seizure 6 pretty similar with CNS lymphoma, whose most common presenting clinical conditions are symptoms of increased intracranial pressure and personality changes, followed by ataxia and hemiparesis, 10 which corresponds well with our findings. Seizure is relatively rare for lymphoma compare to glioma. In addition, it is frequently almost impossible to differentiate between GBM (glioblastoma multiforme) and CNS lymphoma by conventional MR images. 11 In this study, many patients were not suspected to have a CNS lymphoma before histological assessment, thus states the importance of biopsy in diagnosing CNS lymphoma. The only thing that would attract our attention is that the clinical course of lymphoma is usually much shorter compared with glioma. However, new advanced MRI techniques, such as diffusion tensor imaging, and positron-emission tomography (PET) and single photon-emission tomography (SPECT) metabolic imaging have identified characteristic finding in CNS lymphoma that may aid in differentiation of CNS lymphomas and other CNS lesions in the near future. 9, 12 MR images of CNS lymphoma lesions are usually enhanced with contrast, hyperintense on diffusion-weighted imaging (DWI), in T2WI isoto hypointense. 11 The hyperintensity on DWI is related with its high cellularity, and the reduction in extracellular space caused by tumor cellularity will cause a reduction in the apparent diffusion coefficient (ADC) value.
Most tumors are located in cerebral hemisphere and periventricular location, usually involving the corpus callosum or basal ganglia. 7 It's consistent with our findings that the tumor usually involving the white matter, and following the course of the nerve fibers. It did not restrict in certain lobe of the brain, but it would follow the nerve fibers and might involve more than one lobe of the brain. It is very often on T1W1 contrast images, the tumors are looked like the paint strokes. It is more common to find multiple tumor (more than one lesion) in lymphoma (24% in our series shows multiple lesions) compare to glioma (5% of gliomas are multicentric). 13 In conclusion, consideration of the possibility of a CNS lymphoma should be done when it shows rapid progression of neurological worsening. The suspicion toward CNS lymphoma should be even higher when intracranial mass in MR images are markedly enhanced by contrast, in T1W1 show iso-to hypointense lesions while in T2W1 iso-to hypointense with marked perifocal edema, and hyperintense in DWI. It's usually involving white matter of cerebral hemisphere and periventricular area.
